|
C5ORF34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.80779999997749E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73440000028613E-07 |
| Normal-vs-Stage2 |
9.73689995298344E-09 |
| Normal-vs-Stage3 |
4.104700E-03 |
| Normal-vs-Stage4 |
1.022650E-01 |
| Stage1-vs-Stage2 |
4.230400E-02 |
| Stage1-vs-Stage3 |
9.395700E-02 |
| Stage1-vs-Stage4 |
5.570300E-02 |
| Stage2-vs-Stage3 |
1.738410E-03 |
| Stage2-vs-Stage4 |
2.298300E-03 |
| Stage3-vs-Stage4 |
4.971200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023420E-04 |
| Normal-vs-AfricanAmerican |
9.643900E-04 |
| Normal-vs-Asian |
1.361010E-03 |
| Caucasian-vs-AfricanAmerican |
5.328400E-01 |
| Caucasian-vs-Asian |
9.502600E-01 |
| AfricanAmerican-vs-Asian |
5.849000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.444600E-04 |
| Normal-vs-Female |
2.34580000002538E-06 |
| Male-vs-Female |
4.494200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63449999979193E-07 |
| Normal-vs-Age(41-60Yrs) |
8.24640000000043E-05 |
| Normal-vs-Age(61-80Yrs) |
4.362600E-04 |
| Normal-vs-Age(81-100Yrs) |
8.970200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.728800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.597800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.548000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.981800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.246980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.571960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.564200E-02 |
| Classical-VS-Follicular |
2.90920000001194E-06 |
| Classical-VS-Other |
8.850400E-01 |
| Classical-VS-Normal |
3.401500E-04 |
| Tall-VS-Follicular |
3.44549999975463E-07 |
| Tall-VS-Other |
2.028800E-01 |
| Tall-VS-Normal |
4.429200E-01 |
| Follicular-VS-Other |
1.752380E-01 |
| Follicular-VS-Normal |
7.64499574756883E-11 |
| Other-VS-Normal |
1.051230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.89809970360966E-10 |
| Normal-vs-N1 |
1.380800E-01 |
| N0-vs-N1 |
3.883100E-03 |
|
|
